Sangamo Therapeutics (SGMOQ) Short-term Investments (2010 - 2025)

Sangamo Therapeutics has reported Short-term Investments for 16 years, with the latest figure at $912000.0 in Q3 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $912000.0 in Q3 2025; TTM through Sep 2025 was $912000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $197.7 million, down 61.25% from the prior year.
• Short-term Investments was $912000.0 for Q3 2025 at Sangamo Therapeutics, roughly flat from $916000.0 in the prior quarter.
• The five-year high for Short-term Investments was $464.1 million in Q1 2021, with the low at $912000.0 in Q3 2025.
• Average Short-term Investments over 5 years is $185.1 million, with a median of $197.7 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2023: Short-term Investments surged 82.25% in 2021, then slumped 65.48% in 2023.
• Over 5 years, Short-term Investments stood at $197.7 million in 2021, then rose by 10.79% to $219.0 million in 2022, then plunged by 65.48% to $75.6 million in 2023, then sank by 98.79% to $916000.0 in 2024, then slipped by 0.44% to $912000.0 in 2025.
• The last three Short-term Investments figures came in at $912000.0 (Q3 2025), $916000.0 (Q1 2024), and $75.6 million (Q3 2023), per Business Quant data.